문의해 주셔서 감사합니다.
contact.you.lab.product.request.text
(Business Unit Performance Materials, Sales Support Team)
Gedung AIA Central, Level 39, Jl. Jend. Sudirman Kav. 48A, Jakarta Selatan, Indonesia
+62 21 2988 8557
성공! 귀하의 문의가 영업팀에 제출되었습니다.
pim.add.to.wishlist.popup.error
We have found 60 items.
| 요청자의 연락처 세부 정보 | |
| Full name | |
| Company | |
| Position | |
| Telephone number | |
| Work email address | |
| Shipping address | |
Thank you. Your request has been sent.
Bilastine is a white to off-white crystalline powder that is sparingly soluble in methylene chloride and practically insoluble in acetone. It has an assay range of 98.0% to 102.0%.
Products still subject to third-party patent protection might be available solely for R&D purposes.
**Product Overview: Febuxostat – A Robust Solution for Gout Management** Refarmed Chemicals presents Febuxostat, a meticulously prepared medication aimed at alleviating the pain and discomfort associated with gout. Made from a refined white powder, Febuxostat stands out in the pharmaceutical industry as a Xanthine Oxidase Inhibitor, crucial for managing hyperuricemia and recurrent gout attacks. Structured to meet corporate expectations, Febuxostat is a testament to Refarmed Chemicals' 30-year expertise in delivering quality generic and branded medications. Manufactured in compliance with strict guidelines, including the Drug Master File (DMF) and certifications such as WC and GMP, this product is a model of reliability and efficacy. Febuxostat's fundamental use is to decrease blood uric acid levels, offering those afflicted with gout a pathway to recovery by preventing acute flare-ups, and mitigating inflammation and pain in the joints. As a white, soluble powder, Febuxostat is highly soluble in DMSO and slightly soluble in methanol and water, simplifying its integration into diverse medical formulations. Clinical trials have informed a standard starting dosage of 40 mg, adjustable up to 80 mg based on individual patient requirements and the severity of symptoms. In its commitment to patient welfare, Refarmed Chemicals underlines potential side effects ranging from nausea and headaches to rashes, ensuring informed usage of Febuxostat. In alignment with our promise of transparency and safety, we advise consulting healthcare professionals for precise diagnotics and treatment plans. Furthermore, users should be attentive to contraindications, noting that Febuxostat is unsuitable for patients with severe liver or kidney disease, or for women who are pregnant or breastfeeding. Refarmed Chemicals' Febuxostat exceeds industry standards with its impressive assay value of 98.0% - 102.0% purity and a precise control of impurities, ensuring that the product meets stringent quality criteria. The company's analytical rigor is reflected in the detailed specification of residual solvents such as Acetone, Ethanol, and Isopropanol. In the journey to deliver improved health outcomes, Refarmed Chemicals' Febuxostat is more than just a medication; it symbolizes our dedication to quality, safety, and corporate responsibility in the global pharmaceutical landscape. [*Note: Product image depicts a detailed specification chart for Febuxostat, reiterating its quality and compositions.*]
Products still subject to third-party patent protection might be available solely for R&D purposes.
Nadifloxacin: Advanced Antibacterial Solution Refarmed Chemicals presents Nadifloxacin, an efficacious fluoroquinolone antibiotic designed for the assured treatment of various bacterial infections. With its potent broad-spectrum activity, Nadifloxacin offers healthcare professionals a robust option for combating Gram-negative and Gram-positive bacteria, that are often responsible for conditions such as urinary tract infections (UTIs), skin and soft tissue infections, respiratory tract infections, and certain sexually transmitted infections (STIs). Nadifloxacin's pharmacological profile indicates it is generally administered orally via tablets or suspension, with dosing regimens from 500-1000 mg every 12 hours, though this may adjust based on infection severity and individual patient requirements. This medication underscores its commitment to quality and safety, presenting a product that is white to yellowish in crystalline powder form, ensuring high purity with an assay value of ≥ 99.0%. Made with stringent adherence to Good Manufacturing Practice (GMP) standards, Nadifloxacin is both soluble and stable in various solvents, including sodium hydroxide TS and N,N-dimethylformamide (DMF), offering versatile formulation options. Its melting point ranges from 246-250°C, emphasizing its stability under a broad spectrum of conditions. Clarity and color of the solution are maintained as clear, colorless to slight yellow, with stringent checks on impurities – including heavy metals and arsenics kept to minimum levels, aligning with industry standards. While side effects can include nausea, vomiting, diarrhea, and other conditions, they are closely monitored, ensuring optimal patient safety. Patients with hypersensitivity, seizure histories, or on interfering medications are advised to avoid this product and consult healthcare professionals. Nadifloxacin's efficacy is matched only by Refarmed Chemicals' attention to detail and commitment to patient health. With transparent documentation and certification, consumers are assured of the product's integrity, supplemented by the comprehensive information provided by the DKSH Group to facilitate informed decision-making. As a corporate customer looking to source reliable antibiotics, Nadifloxacin represents a high-grade pharmaceutical ingredient that stands for efficacy and safety in the management of bacterial infections.
Products still subject to third-party patent protection might be available solely for R&D purposes.
Ketotifen Hydrogen Fumarate is a specialized pharmaceutical compound with profound implications in the management of allergic conditions. As a white to off-white crystalline powder, it embodies the archetypal pharmaceutical intermediate that serves a critical role in the synthesis of medications aimed at mitigating allergic symptoms. This compound, with the molecular formula C19H19NOS·C4H4O4 and a molecular weight of 425.50 g/mol, is an epitome of pharmacological innovation, designed to alleviate discomfort associated with allergic rhinitis and conjunctivitis, while also playing a preventive role in asthma management. Fabricated with meticulous precision, Ketotifen Hydrogen Fumarate is both soluble in water and ethanol, ensuring versatility in its application for medical formulations. With a melting point between 160-163°C, where it starts decomposing, this substance remains stable under a wide range of conditions, ensuring a dependable shelf-life for pharmaceutical products. When handling this product, adherence to stringent safety guidelines, including the use of personal protective equipment, is imperative to minimize potential contact risks. It demands storage in cool, dry environments, shielded from light and moisture, to preserve its integrity. Respected for its non-sedating nature, Ketotifen distinctively works by inhibiting the discharge of histamine and other mediators from mast cells, thus curtailing the cascade of allergic reactions without inducing significant drowsiness. The side effects are minimal, with mild drowsiness, dry mouth, and nausea being among the most common, while more severe reactions such as confusion or hallucinations are decidedly rare. An advocate for quality and safety, Refarmed Chemicals, a leading pharmaceutical ingredient manufacturer, assures regulatory compliance, with Ketotifen Hydrogen Fumarate approved by the FDA for prescribed use. As such, corporate customers seeking a reliable cornerstone for their allergy-treating formulations will find this product to be a formidable addition to their pharmaceutical repertoire.
Products still subject to third-party patent protection might be available solely for R&D purposes.